Kilombero and Ulanga antiretroviral cohort study...

In the News

Scientists: Target TB interventions on these transmission hotspots

(Dar es Salaam, September 14, 2017). Scientists at Ifakara Health Institute (IHI) have recently adapted a method for identifying tuberculosis (TB) transmission hotpots using a new technique that could revolutionize …

Research Office, Lab Technicians required

IHI is looking for suitably qualified Research Officer and Laboratory Technicians to fill vacant positions in the Laboratory Unit in Bagamoyo. To apply or share, get more details about these …

Recent Projects

Understanding and enhancing approaches to quality improvement in small and medium sized private facilities in sub-Saharan Africa

This is an evaluation study that IHI is conducting in collaboration with London school of hygiene and tropical medicine. The research takes place in the context of an innovative intervention …

Vaccine Delivery Costing Study

As countries drive towards achieving high and equitable coverage of life-saving vaccines, the availability of sustainable, equitable, and predictable financing for vaccine delivery is essential. Over the last two decades, …

Kilombero and Ulanga Antiretroviral Cohort Study (KIULARCO)

In 2005 a cohort study of HIV-positive patients at the St Francis Referral Hospital, Ifakara was started. Patients consenting to be regularly seen in the Chronic Diseases Clinic Ifakara (CDCI), to have their data analyzed and blood stored in a biobank for further analysis are prospectively enrolled. The cohort offers the opportunity for many nested research projects addressing questions on prevalence of associated diseases, clinical management and outcomes, aiming at addressing specific needs of this rural population and at improvement of services. A special focus is co-infection with tuberculosis, cryptococcal meningitis, and other co-morbidities. Pediatric HIV infection – considered a neglected disease – and HIV in pregnant women is an important research line. So far, almost 9000 patients have been enrolled, of these 3500 are currently under active follow-up. 18 papers have been published; many more are in preparation or currently running. KIULARCO also offers an ideal platform for affiliated treatment studies – within international collaborations or as single center study.

Lead Scientists

Maja Weisser

Herry Mapesi

George Sekilango

Partners

Swiss Tropical and Public Health Insitute

Funders

Ifakara Health Institute
Swiss Tropical and Public Health Institute

Projects Location

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016